[-] Show simple item record

dc.contributor.advisorDeutscher, Susan L.eng
dc.contributor.authorSoendergaard, Metteeng
dc.contributor.authorZhang, Xiulieng
dc.contributor.authorBates, Maura K.eng
dc.contributor.authorQuinn, Thomas P. (Thomas Patrick), 1961-eng
dc.contributor.corporatenameUniversity of Missouri--Columbia. School of Medicineeng
dc.contributor.meetingnameHealth Sciences Research Day (2010 : University of Missouri)eng
dc.date.issued2010eng
dc.description.abstractThe purpose of this study was to radiolabel a novel ErbB-2-avid peptide, discovered from bacteriophage display, with [99mTc(H2 O)3 (CO)3 ]+ and evaluate the in vitro cellular targeting and in vivo tumor imaging properties of the peptide in a mouse model of human breast cancer.eng
dc.format.extent1 pageeng
dc.identifier.urihttp://hdl.handle.net/10355/9227
dc.languageEnglisheng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. Health Sciences Research Dayeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectcancer screeningeng
dc.subjecttumor imagingeng
dc.subject.FASTBreast -- Cancer -- Imagingeng
dc.subject.FASTPeptideseng
dc.subject.FASTBacteriophageseng
dc.titleEvaluation of [99mTC(CO)3]-labeled ERBB-2-targeting peptides for breast carcinoma imaging [abstract]eng
dc.typeAbstracteng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record